Skip to content

Clinical trials

Phase 3 Alzheimer Disease trials in Croatia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 3 Country / region: Croatia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20082
20121
20132
20143
20151
20162
20181
20201
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated8
Completed7
Recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
TauRx Therapeutics Ltd3
Axovant Sciences Ltd.2
GlaxoSmithKline2
H. Lundbeck A/S2
Hoffmann-La Roche2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Pfizer2
Karuna Therapeutics, Inc., a Bristol Myers Squibb company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease19
Dementia6
Brain Diseases3
Cognitive Dysfunction3
Neurodegenerative Diseases3
Psychomotor Agitation3
Frontotemporal Dementia1
Lymphoma, Follicular1
Mental Disorders1
Nervous System Diseases1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.